Therese Seierstad - Search Results

Year	Number of Results
2003	1
2004	1
2007	3
2008	2
2009	3
2010	5
2011	5
2012	4
2013	7
2014	5
2015	5
2016	4
2017	3
2018	6
2019	9
2020	4
2021	7
2022	6
2023	4
2024	0

1

MRI Assessment of Changes in Tumor Vascularization during Neoadjuvant Anti-Angiogenic Treatment in Locally Advanced Breast Cancer Patients.

Mo T, Brandal SHB, Geier OM, Engebråten O, Nilsen LB, Kristensen VN, Hole KH, Hompland T, Fleischer T, Seierstad T. Mo T, et al. Among authors: seierstad t. Cancers (Basel). 2023 Sep 21;15(18):4662. doi: 10.3390/cancers15184662. Cancers (Basel). 2023. PMID: 37760629 Free PMC article.

2

Prostate cancer radiogenomics reveals proliferative gene expression programs associated with distinct MRI-based hypoxia levels.

Skingen VE, Hompland T, Fjeldbo CS, Salberg UB, Helgeland H, Ragnum HB, Aarnes EK, Vlatkovic L, Hole KH, Seierstad T, Lyng H. Skingen VE, et al. Among authors: seierstad t. Radiother Oncol. 2023 Nov;188:109875. doi: 10.1016/j.radonc.2023.109875. Epub 2023 Aug 26. Radiother Oncol. 2023. PMID: 37640161

3

Monoparametric high-resolution diffusion weighted MRI as a possible first step in an MRI-directed diagnostic pathway for men with suspicion of prostate cancer.

Reijnen JS, Ryg U, Marthinsen JB, Schönhardt I, Seierstad T, Hole KH. Reijnen JS, et al. Among authors: seierstad t. Front Oncol. 2023 Jan 31;13:1102860. doi: 10.3389/fonc.2023.1102860. eCollection 2023. Front Oncol. 2023. PMID: 36798813 Free PMC article.

4

Impact of human telomerase reverse transcriptase peptide vaccine combined with androgen deprivation therapy and radiotherapy in de novo metastatic prostate cancer: Long-term clinical monitoring.

Lilleby W, Seierstad T, Inderberg EM, Hole KH. Lilleby W, et al. Among authors: seierstad t. Int J Cancer. 2023 May 15;152(10):2166-2173. doi: 10.1002/ijc.34448. Epub 2023 Feb 4. Int J Cancer. 2023. PMID: 36715014 Clinical Trial.

5

Prognostic significance of conventional and volumetric PET parameters with and without partial volume correction in the assessment of head and neck squamous cell carcinoma.

Zirakchian Zadeh M, Asadollahi S, Kaghazchi F, Raynor WY, Mehdizadeh Seraj S, Werner TJ, Seierstad T, Korostoff J, Swisher-McClure S, Alavi A, Revheim ME. Zirakchian Zadeh M, et al. Among authors: seierstad t. Nucl Med Commun. 2022 Jul 1;43(7):800-806. doi: 10.1097/MNM.0000000000001573. Epub 2022 May 13. Nucl Med Commun. 2022. PMID: 35552334

6

A Prospective Study of High Dose-Rate Brachytherapy or Stereotactic Body Radiotherapy of Intra-Prostatic Recurrence: Toxicity and Long Term Clinical Outcome.

Ryg U, Seierstad T, Nilsen LB, Hellebust TP, Djupvik LH, Gustafson H, Hydal J, Kishan AU, Hole KH, Lilleby W. Ryg U, et al. Among authors: seierstad t. Front Oncol. 2022 Apr 5;12:861127. doi: 10.3389/fonc.2022.861127. eCollection 2022. Front Oncol. 2022. PMID: 35463376 Free PMC article.

7

A prognostic hypoxia gene signature with low heterogeneity within the dominant tumour lesion in prostate cancer patients.

Salberg UB, Skingen VE, Fjeldbo CS, Hompland T, Ragnum HB, Vlatkovic L, Hole KH, Seierstad T, Lyng H. Salberg UB, et al. Among authors: seierstad t. Br J Cancer. 2022 Jul;127(2):321-328. doi: 10.1038/s41416-022-01782-x. Epub 2022 Mar 24. Br J Cancer. 2022. PMID: 35332267 Free PMC article.

8

Quantification of Tumor Hypoxia through Unsupervised Modelling of Consumption and Supply Hypoxia MR Imaging in Breast Cancer.

Mo T, Brandal SHB, Köhn-Luque A, Engebraaten O, Kristensen VN, Fleischer T, Hompland T, Seierstad T. Mo T, et al. Among authors: seierstad t. Cancers (Basel). 2022 Mar 4;14(5):1326. doi: 10.3390/cancers14051326. Cancers (Basel). 2022. PMID: 35267636 Free PMC article.

9

MRI-based automatic segmentation of rectal cancer using 2D U-Net on two independent cohorts.

Knuth F, Adde IA, Huynh BN, Groendahl AR, Winter RM, Negård A, Holmedal SH, Meltzer S, Ree AH, Flatmark K, Dueland S, Hole KH, Seierstad T, Redalen KR, Futsaether CM. Knuth F, et al. Among authors: seierstad t. Acta Oncol. 2022 Feb;61(2):255-263. doi: 10.1080/0284186X.2021.2013530. Epub 2021 Dec 17. Acta Oncol. 2022. PMID: 34918621

10

Localization of primary prostate cancer: FACBC PET/CT compared with multiparametric MRI using histopathology as reference standard.

Hole KH, Tulipan AJ, Reijnen JS, Hernes E, Vlatkovic L, Lie AK, Revheim ME, Seierstad T. Hole KH, et al. Among authors: seierstad t. Am J Nucl Med Mol Imaging. 2021 Oct 15;11(5):387-394. eCollection 2021. Am J Nucl Med Mol Imaging. 2021. PMID: 34754609 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

65 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year